Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph not_applicable
3
75%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

completed375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completednot_applicable

CHILD (Child Health and Infection With Low Density) Malaria

NCT05567016
recruitingnot_applicable

Pharmacy-based PrEP for Young Women Who Sell Sex in Zimbabwe

NCT06348069
completednot_applicable

Emotions Immunology and Breast Cancer

NCT03609671
completedphase_1

Evaluation of Cohera TissuGlu in the Management of Wound Drainage Following Abdominoplasty

NCT01331798

Clinical Trials (4)

Showing 4 of 4 trials
NCT05567016Not Applicable

CHILD (Child Health and Infection With Low Density) Malaria

Completed
NCT06348069Not Applicable

Pharmacy-based PrEP for Young Women Who Sell Sex in Zimbabwe

Recruiting
NCT03609671Not Applicable

Emotions Immunology and Breast Cancer

Completed
NCT01331798Phase 1

Evaluation of Cohera TissuGlu in the Management of Wound Drainage Following Abdominoplasty

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4